Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) initiative.

Autor: Pishvaian MJ; Perthera, Inc, McLean, VA, USA.; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA., Joseph Bender R; Perthera, Inc, McLean, VA, USA., Matrisian LM; The Pancreatic Cancer Action Network, Manhattan Beach, CA, USA., Rahib L; The Pancreatic Cancer Action Network, Manhattan Beach, CA, USA., Hendifar A; Cedars-Sinai Medical Center, Los Angeles, CA, USA., Hoos WA; The Pancreatic Cancer Action Network, Manhattan Beach, CA, USA., Mikhail S; Ohio State University, Columbus, OH, USA., Chung V; City of Hope Cancer Center, Duarte, CA, USA., Picozzi V; Virginia Mason Medical Center, Seattle, WA, USA., Heartwell C; Perthera, Inc, McLean, VA, USA., Mason K; Perthera, Inc, McLean, VA, USA., Varieur K; Perthera, Inc, McLean, VA, USA., Aberra M; Perthera, Inc, McLean, VA, USA., Madhavan S; Perthera, Inc, McLean, VA, USA.; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA., Petricoin E 3rd; Perthera, Inc, McLean, VA, USA., Brody JR; Perthera, Inc, McLean, VA, USA.; Jefferson Pancreatic, and Related Cancer Center, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.

Publikováno v: Oncotarget [Oncotarget] 2016 Nov 08; Vol. 8 (48), pp. 83446-83456. Date of Electronic Publication: 2016 Nov 08 (Print Publication: 2017).